is bpc-157 safe The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety what are the side effects

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions

2), S38S51 (2008)

Month one going very well

Your healthcare provider will monitor levels and adjust dosing to maintain optimal ranges without over-supplementation